Advances in Animal Models of Hepatitis B Virus Infection

Open access


Hepatitis B virus (HBV) infection seriously affects human health. Stable and reliable animal models of HBV infection bear significance in studying pathogenesis of this health condition and development of intervention measures. HBV exhibits high specificity for hosts, and chimpanzee is long used as sole animal model of HBV infection. However, use of chimpanzees is strictly constrained because of ethical reasons. Many methods were used to establish small-animal models of HBV infection. Tupaia is the only nonprimate animal that can be infected by HBV. Use of HBV-related duck hepatitis virus and marmot hepatitis virus infection model contributed to evaluation of mechanism of HBV replication and HBV treatment methods. In recent years, development of human–mouse chimeric model provided possibility of using common experimental animals to carry out HBV research. These models feature their own advantages and disadvantages and can be complementary in some ways. This study provides an overview of current and commonly used animal models of HBV infection.

If the inline PDF is not rendering correctly, you can download the PDF file here.

  • 1 Sa-Nguanmoo P Rianthavorn P Amornsawadwattana S et al. Hepatitis B virus infection in non-human primates. Acta Virol 2009 53(2): 73-82.

  • 2 Komiya Y Katayama K Yugi H et al. Minimum infectious dose of hepatitis B virus in chimpanzees and difference in the dynamics of viremia between genotype A and genotype C. Transfusion 2008 48(2): 286-294.

  • 3 Gagneux P Muchmore EA. The chimpanzee model: contributions and considerations for studies of hepatitis B virus. Methods Mol Med 2004 96 (289-318.

  • 4 Amako Y Tsukiyama Kohara K Katsume A et al. Pathogenesis of hepatitis C virus infection in Tupaia belangeri. J Virol 2010 84(1): 303-311.

  • 5 Su J Yan R Gan Y et al. Study on hepatitis B virus infection in adult tupaia. Chinese Journal of Pathology 1987 16 (2): 103-105.

  • 6 Walter E Keist R Niederost B et al. Hepatitis B virus infection of tupaia hepatocytes in vitro and in vivo. Hepatology 1996 24(1): 1-5.

  • 7 Yan RQ Su J J Huang DR et al. Human hepatitis B virus and hepatocellular carcinoma. I. Experimental infection of tree shrews with hepatitis B virus. J Cancer Res Clin Oncol 1996 122(5): 283-288.

  • 8 Li J Liu H Han C et al. Effect of virus inoculation dose on adult tupaia infected with HBV. Journal of Immunology 2012 28 (12): 1056-1060.

  • 9 Wang Q Schwarzenberger P Yang F et al. Experimental chronic hepatitis B infection of neonatal tree shrews (Tupaia belangeri chinensis): a model to study molecular causes for susceptibility and disease progression to chronic hepatitis in humans. Virol J 2012 9(170.

  • 10 Yan H Zhong G Xu G et al. Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus. Elife 2012 1: e00049.

  • 11 Tong Y Tong S Zhao X et al. Initiation of duck hepatitis B virus infection requires cleavage by a furin –like protease. J Virol 2010 84(9): 4569-4578.

  • 12 Tohidi Esfahani R Vickery K Cossart Y. The early host innate immune response to duck hepatitis B virus infection. J Gen Virol 2010 91(Pt 2): 509-520.

  • 13 Reaiche GY Le Mire MF Mason WS et al. The persistence in the liver of residual duck hepatitis B virus covalently closed circular DNA is not dependent upon new viral DNA synthesis. Virology 2010 406(2): 286-292.

  • 14 Yang Q Zhao X Zang L et al. Anti-hepatitis B virus activities of alpha -DDB -FNC a novel nucleoside -biphenyldicarboxylate compound in cells and ducks and its anti-immunological liver injury effect in mice. Antiviral Res 2012 96(3): 333-339.

  • 15 Menne S Cote PJ. The woodchuck as an animal model for pathogenesis and therapy of chronic hepatitis B virus infection. World J Gastroenterol 2007 13(1): 104-124.

  • 16 Fletcher SP Chin DJ Ji Y et al. Transcriptomic analysis of the woodchuck model of chronic hepatitis B. Hepatology 2012 56(3): 820-830.

  • 17 Fletcher SP Chin DJ Cheng DT et al. Identification of an intrahepatic transcriptional signature associated with selflimiting infection in the woodchuck model of hepatitis B. Hepatology 2013 57(1): 13-22.

  • 18 Menne S Butler SD George AL et al. Antiviral effects of lamivudine emtricitabine adefovir dipivoxil and tenofovir disoproxil fumarate administered orally alone and in combination to woodchucks with chronic woodchuck hepatitis virus infection. Antimicrob Agents Chemother 2008 52(10): 3617-3632.

  • 19 Dandri M Petersen J. Chimeric mouse model of hepatitis B virus infection. J Hepatol 2012 56(2): 493-495.

  • 20 Ilan E Burakova T Dagan S et al. The hepatitis B virustrimera mouse: a model for human HBV infection and evaluation of anti-HBV therapeutic agents. Hepatology 1999 29(2): 553-562.

  • 21 Ohashi K Marion PL Nakai H et al. Sustained survival of human hepatocytes in mice: A model for in vivo infection with human hepatitis B and hepatitis delta viruses. Nat Med 2000 6(3): 327-331.

  • 22 Dandri M Burda MR Torok E et al. Repopulation of mouse liver with human hepatocytes and in vivo infection with hepatitis B virus. Hepatology 2001 33(4): 981-988.

  • 23 Dandri M Burda MR Zuckerman DM et al. Chronic infection with hepatitis B viruses and antiviral drug evaluation in uPA mice after liver repopulation with tupaia hepatocytes. J Hepatol 2005 42(1): 54-60.

  • 24 Rhim JA Sandgren EP Palmiter RD et al. Complete reconstitution of mouse liver with xenogeneic hepatocytes. Proc Natl Acad Sci U S A 1995 92(11): 4942-4946.

  • 25 Lutgehetmann M Bornscheuer T Volz T et al. Hepatitis B virus limits response of human hepatocytes to interferonalpha in chimeric mice. Gastroenterology 2011 140(7): 2074-2083.

  • 26 Azuma H Paulk N Ranade A et al. Robust expansion of human hepatocytes in Fah-/-/Rag2-/-/Il2rg-/-mice. Nat Biotechnol 2007 25(8): 903-910.

  • 27 Su B Liu C Xiang D et al. Xeno-repopulation of Fah -/-Nod/Scid mice livers by human hepatocytes. Sci China Life Sci 2011 54(3): 227-234.

  • 28 Bility MT Zhang L Washburn ML et al. Generation of a humanized mouse model with both human immune system and liver cells to model hepatitis C virus infection and liver immunopathogenesis. Nat Protoc 2012 7(9): 1608-1617.

Journal information
Cited By
All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 256 169 4
PDF Downloads 124 85 3